MannKind (MNKD) , a biopharmaceutical company, focuses on the discovery, development and commercialization of therapeutic products for diabetes in the U.S. This stock traded up 22.3% to 92 cents per share in Tuesday's trading session.
From a technical perspective, MannKind exploded sharply higher on Tuesday right above some near-term support at 75 cents per share with massive upside volume flows. This high-volume spike to the upside briefly pushed shares of MannKind back above its 20-day moving average of 96 cents per share, before the stock closed just below that level at 92 cents per share. Shares of MannKind are now quickly moving within range of triggering a major breakout trade above some key near-term overhead resistance. That trade will trigger if this stock manages to take out Tuesday's intraday high of 98 cents per share and then above more key resistance at 99 cents per share with high volume.